The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II open-label randomized multi-centre study of neoadjuvant olaparib in patients (pts) with platinum sensitive (PS) relapsed high grade serous ovarian cancer (OC): The NEO trial.
 
Yada Kanjanapan
No Relationships to Disclose
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Taymaa May
No Relationships to Disclose
 
Michelle K. Wilson
Travel, Accommodations, Expenses - MSD
 
Marcus Bernardini
Honoraria - AstraZeneca
 
Patricia Ann Shaw
Honoraria - AstraZeneca
 
Ignace Vergote
Consulting or Advisory Role - Amgen (Inst); Array Biopharma (Inst); AstraZeneca (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Endocyte (Inst); Fresenius (Inst); GE Healthcare (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Hampton Medical Conferences (Inst); Intuitive Surgical (Inst); Janssen-Cilag (Inst); Kendle (Inst); Lilly (Inst); MedImmune (Inst); Menarini (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Nektar (Inst); Novo Nordisk (Inst); Oasmia Pharmaceutical AB (Inst); PharmaMar (Inst); Phillips Gilmore Oncology (Inst); Quintiles (Inst); Roche (Inst); Sanofi (Inst); Schering-Plough (Inst); Sigma-Tau (Inst); Telik (Inst); TRM Oncology (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Eisai (Inst); Exelixis (Inst); Fresenius Biotech (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Morphotek (Inst); Nektar (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Proacta (Inst); Quintiles (Inst); Roche (Inst); Sandoz (Inst); Sanofi (Inst); Schering-Plough (Inst); Vifor Pharma (Inst); Wyeth (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GCI Health; Oasmia Pharmaceutical AB; PharmaMar; Roche
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Research Funding - Aprea AB (Inst)
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Aprea AB; Clovis Oncology
 
Diane M. Provencher
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
 
Iain A. McNeish
Consulting or Advisory Role - Clovis Oncology
 
Prafull Ghatage
No Relationships to Disclose
 
Jonathan A. Ledermann
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Clovis Oncology; Pfizer; Roche
Research Funding - AstraZeneca (Inst)
 
Nicoletta Colombo
Employment - Ignyta (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech
 
Charlie Gourley
Honoraria - AstraZeneca; Clovis Oncology; Nucana
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); Nucana (Inst)
Research Funding - Aprea AB (Inst); AstraZeneca (Inst); Novartis (Inst); Nucana
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
 
Johanne Weberpals
Consulting or Advisory Role - Abbvie; AstraZeneca; EMD Serono
Research Funding - Abbvie; AstraZeneca; EMD Serono
 
Janelle Ramsahai
No Relationships to Disclose
 
Nicole Ricker
Employment - Ozmosis Research
 
Sarah Accardi
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Amit M. Oza
Honoraria - WebRx
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca